Factors associated with the effect of interferon‐α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|45|12|1195-1202

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.45, Iss.12, 2015-12, pp. : 1195-1202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk of hepatocellular carcinoma in cirrhotic hepatitis B virus patients during nucleoside/nucleotide analog therapy

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 8, 2015-08 ,pp. : 872-879

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mutations in non-structural 5A and rapid viral response to pegylated interferon-α-2b plus ribavirin therapy are associated with therapeutic efficacy in patients with genotype 1b chronic hepatitis C

By                                                  

International Journal of Molecular Medicine, Vol. 30, Iss. 5, 2012-01 ,pp. : 1048-1052

Spandidos Publications

Access to resources Recommend Favorite

Efficacy and Tolerability of Pegylated Interferon-α2a plus Ribavirin versus Pegylated Interferon-α2b plus Ribavirin in Treatment-Naive Chronic Hepatitis C Patients

By  

Intervirology, Vol. 53, Iss. 3, 2010-01 ,pp. : 146-153

Karger

Access to resources Recommend Favorite

Efficacy of Interferon-α in the Treatment of Chronic Hepatitis C in Dialysis Patients: Two Therapeutic Protocols Compared

By  

Nephron Clin Pract, Vol. 103, Iss. 1, 2005-12 ,pp. : c8-c11

Karger

Access to resources Recommend Favorite

Interferon Therapy of Chronic Hepatitis B

By  

Intervirology, Vol. 57, Iss. 3-4, 2014-07 ,pp. : 163-170

Karger

Access to resources Recommend Favorite